Given their central role in inflammation, inflammatory mediators are key targets for therapeutic intervention. Anti-inflammatory drugs like NSAIDs inhibit the synthesis of prostaglandins. Biologics, such as monoclonal antibodies, can specifically target cytokines like TNF-α. These therapies aim to modulate the inflammatory response to treat various inflammatory diseases effectively.
